消费者

关于我们

关于我们

截至2050年，世界人口将超过90亿，这将给全球人类的食品保障带来前所未有的挑战。另一方面，全球消费者都渴望购买更健康的食品。

在杜邦，我们充分发挥科学的作用，改善食品营养价值，确保食品安全，并寻找创新的可持续的解决方案，以养育不断增长的人口。杜邦的科学家和商务专家与全球的食品制造商和生产商紧密合作让食品更安全、更健康、更美味和更易于生产。

杜邦营养与健康

杜邦营养与健康事业部把对食品和营养的深刻理解和最前沿的创新成果与专业科技相结合，为食品、饮料、制药及膳食补充剂行业提供无与伦比的价值。

创新发展

对我们而言，创新需要广泛的产品组合、科学验证以及对技术和我们客户价值链、消费者市场的深刻理解。

最新消息

DuPont Opens World-Class Probiotics Fermentation Unit

ROCHESTER, N.Y., July 15, 2019 – DuPont (NYSE: DD) today announced the opening of a new state-of-the-art probiotics fermentation unit at its Rochester, New York, facility. Construction of the unit was completed in March as part of an overall $100MM investment to expand probiotics capacity. The facility is now producing high-quality probiotics for the dietary supplement and food and beverage industries, which have the potential to provide health benefits to consumers of all ages.

DuPont Chosen to Provide Probiotics for International Pediatric Sepsis Research

WILMINGTON, Del., April 25, 2019 – It is estimated that nearly 3 million newborns and 1.2 million children suffer from sepsis globally each year1, with limited effective forms of prevention currently available. To help combat this, DuPont Nutrition & Biosciences (DuPont), the global leader in probiotics, will provide clinical trial probiotic and prebiotic products to the Centre for Global Child Health at The Hospital for Sick Children (SickKids) in Toronto for its research on the effects of probiotics on sepsis in infants.

DuPont Achieves Major Milestone to Expand Probiotics Capacity

ROCHESTER, NY, March 28, 2019 – DuPont today announced it has completed construction on a new, state-of-the art probiotics fermentation unit at its Rochester, New York, facility. The unit, now largest in the world, is part of a multiphase nearly $100 million investment to expand probiotics capacity and enhance the company’s leadership in delivering high-quality, clinically documented probiotics to dietary supplement and food and beverage manufacturers.

全球分布

杜邦是一个以科研为基础的全球企业。杜邦营养与健康事业部致力于益生菌产品的开发与研究。 位于芬兰的健康营养研究中心为杜邦全球益生菌功效提供研究支持，特有的ENTEROMIXTM仿生试验技术能够模拟人体肠道环境，跟踪和研究益生菌和益生元在人体消化道中的真正表现。凭借这个中心，我们也一跃成为全球唯一拥有健康营养研究中心的菌种供应商。 在美国，我们的科学研究中心对益生菌生产技术、微生物基因组学及微生物学，以及产品稳定性进行充分研究和实践。在丹麦，杜邦科学家们致力于分析学及代谢组学临床研究。